MIBG

RADIATION3 trials

Sponsors

Nationwide Children's Hospital, Samsung Medical Center, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

MIBG Avid TumorsNewly Diagnosed High Risk NeuroblastomaVery High Risk Neuroblastoma

Phase 2

MIBG Therapy for Patients With MIBG Avid Tumors

Active, not recruitingNCT02378428

Nationwide Children's HospitalMIBG Avid Tumors

Start: 2014-03-01End: 2025-12-31Target: 65Updated: 2025-05-13

Response-based Treatment of High-risk Neuroblastoma

Samsung Medical CenterNewly Diagnosed High Risk Neuroblastoma

Start: 2015-04-30End: 2023-03-31Target: 54Updated: 2016-05-24

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

TerminatedNCT03165292

Gustave Roussy, Cancer Campus, Grand ParisVery High Risk Neuroblastoma

Start: 2018-10-01End: 2024-03-28Updated: 2025-09-02

Related Papers

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N

Frontiers in Pediatrics2022-03-1026 citations

Eighty per cent more patients in 10 years of UK molecular radiotherapy

Nuclear Medicine Communications2019-05-0610 citations